Sacramento, CA, United States of America

David Osborn

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of David Osborn

Introduction

David Osborn is a notable inventor based in Sacramento, CA, who has made significant contributions to the field of biotechnology. With a total of six patents to his name, Osborn has focused on developing innovative solutions that enhance the efficiency of various biological processes.

Latest Patents

Among his latest patents, Osborn has developed isolated polypeptides having xylanase activity, which include catalytic domains and carbohydrate binding modules. This invention relates to polynucleotides encoding these polypeptides, as well as nucleic acid constructs, vectors, and host cells that utilize these polynucleotides. Additionally, he has created cellobiohydrolase variants that exhibit increased thermal activity or thermostability, along with the corresponding polynucleotides and methods for their application.

Career Highlights

Throughout his career, David Osborn has worked with prominent companies in the biotechnology sector, including Novozymes A/S and Novozymes, Inc. His work has contributed to advancements in enzyme technology and its applications in various industries.

Collaborations

Osborn has collaborated with several professionals in his field, including Mark Wogulis and Leslie Demars. These partnerships have fostered innovation and the development of new technologies.

Conclusion

David Osborn's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the industry. His work continues to influence advancements in enzyme technology and its applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…